656 related articles for article (PubMed ID: 25786180)
1. Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria.
Boyle MJ; Reiling L; Feng G; Langer C; Osier FH; Aspeling-Jones H; Cheng YS; Stubbs J; Tetteh KK; Conway DJ; McCarthy JS; Muller I; Marsh K; Anders RF; Beeson JG
Immunity; 2015 Mar; 42(3):580-90. PubMed ID: 25786180
[TBL] [Abstract][Full Text] [Related]
2. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.
Reiling L; Richards JS; Fowkes FJ; Wilson DW; Chokejindachai W; Barry AE; Tham WH; Stubbs J; Langer C; Donelson J; Michon P; Tavul L; Crabb BS; Siba PM; Cowman AF; Mueller I; Beeson JG
PLoS One; 2012; 7(9):e45253. PubMed ID: 23028883
[TBL] [Abstract][Full Text] [Related]
3. Targets of complement-fixing antibodies in protective immunity against malaria in children.
Reiling L; Boyle MJ; White MT; Wilson DW; Feng G; Weaver R; Opi DH; Persson KEM; Richards JS; Siba PM; Fowkes FJI; Takashima E; Tsuboi T; Mueller I; Beeson JG
Nat Commun; 2019 Feb; 10(1):610. PubMed ID: 30723225
[TBL] [Abstract][Full Text] [Related]
4. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children.
Irani V; Ramsland PA; Guy AJ; Siba PM; Mueller I; Richards JS; Beeson JG
Clin Infect Dis; 2015 Oct; 61(8):1244-52. PubMed ID: 26136391
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
[TBL] [Abstract][Full Text] [Related]
9. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development.
Richards JS; Arumugam TU; Reiling L; Healer J; Hodder AN; Fowkes FJ; Cross N; Langer C; Takeo S; Uboldi AD; Thompson JK; Gilson PR; Coppel RL; Siba PM; King CL; Torii M; Chitnis CE; Narum DL; Mueller I; Crabb BS; Cowman AF; Tsuboi T; Beeson JG
J Immunol; 2013 Jul; 191(2):795-809. PubMed ID: 23776179
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes.
Sakamoto H; Takeo S; Maier AG; Sattabongkot J; Cowman AF; Tsuboi T
Vaccine; 2012 Mar; 30(11):1972-80. PubMed ID: 22248820
[TBL] [Abstract][Full Text] [Related]
11. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
12. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.
Pandey AK; Reddy KS; Sahar T; Gupta S; Singh H; Reddy EJ; Asad M; Siddiqui FA; Gupta P; Singh B; More KR; Mohmmed A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2013 Feb; 81(2):441-51. PubMed ID: 23184525
[TBL] [Abstract][Full Text] [Related]
13. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
14. Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.
Krishnarjuna B; Andrew D; MacRaild CA; Morales RA; Beeson JG; Anders RF; Richards JS; Norton RS
Sci Rep; 2016 Feb; 6():20613. PubMed ID: 26865062
[TBL] [Abstract][Full Text] [Related]
15. Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.
Chan JA; Stanisic DI; Duffy MF; Robinson LJ; Lin E; Kazura JW; King CL; Siba PM; Fowkes FJ; Mueller I; Beeson JG
Eur J Immunol; 2017 Dec; 47(12):2124-2136. PubMed ID: 28833064
[TBL] [Abstract][Full Text] [Related]
16. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
[TBL] [Abstract][Full Text] [Related]
17. Functional Comparison of Blood-Stage
Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
Front Immunol; 2019; 10():1254. PubMed ID: 31214195
[TBL] [Abstract][Full Text] [Related]
18. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
[TBL] [Abstract][Full Text] [Related]
19. PfMSA180 is a novel Plasmodium falciparum vaccine antigen that interacts with human erythrocyte integrin associated protein (CD47).
Nagaoka H; Sasaoka C; Yuguchi T; Kanoi BN; Ito D; Morita M; Udomsangpetch R; Sattabongkot J; Ishino T; Tsuboi T; Takashima E
Sci Rep; 2019 Apr; 9(1):5923. PubMed ID: 30976034
[TBL] [Abstract][Full Text] [Related]
20. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia.
Okech BA; Corran PH; Todd J; Joynson-Hicks A; Uthaipibull C; Egwang TG; Holder AA; Riley EM
Infect Immun; 2004 Mar; 72(3):1557-67. PubMed ID: 14977962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
